Scarica l'app Stockscreener
3.59
2.71%
-0.10
Dopo l'orario di chiusura:
3.58
-0.010
-0.28%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RLAY Giù?
Forum
Previsione
Precedente Chiudi:
$3.69
Aprire:
$3.72
Volume 24 ore:
1.09M
Relative Volume:
0.60
Capitalizzazione di mercato:
$618.96M
Reddito:
$25.55M
Utile/perdita netta:
$-341.97M
Rapporto P/E:
-1.2821
EPS:
-2.8
Flusso di cassa netto:
$-304.44M
1 W Prestazione:
-2.71%
1M Prestazione:
-0.83%
6M Prestazione:
+10.46%
1 anno Prestazione:
-46.89%
Intervallo 1D:
$3.52
$3.74
Intervallo di 1 settimana:
$3.4446
$3.74
Portata 52W:
$1.775
$10.72
Relay Therapeutics Inc Stock (RLAY) Company Profile
Nome
Relay Therapeutics Inc
Settore
Industria
Telefono
617-370-8837
Indirizzo
60 HAMPSHIRE STREET, CAMBRIDGE
Confronta RLAY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
3.59 | 636.20M | 25.55M | -341.97M | -304.44M | -2.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-17 | Iniziato | Wells Fargo | Equal Weight |
| 2024-09-10 | Ripresa | Goldman | Buy |
| 2024-09-10 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-09-10 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-05-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2023-04-20 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-04-19 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-04-13 | Iniziato | Raymond James | Outperform |
| 2023-02-03 | Iniziato | Oppenheimer | Outperform |
| 2022-09-30 | Iniziato | Barclays | Equal Weight |
| 2022-09-02 | Iniziato | Stifel | Buy |
| 2022-06-06 | Iniziato | Jefferies | Underperform |
| 2022-02-01 | Iniziato | Berenberg | Buy |
| 2021-07-21 | Iniziato | BofA Securities | Buy |
| 2020-12-15 | Reiterato | H.C. Wainwright | Buy |
| 2020-12-08 | Iniziato | JMP Securities | Mkt Outperform |
| 2020-11-05 | Iniziato | H.C. Wainwright | Buy |
| 2020-08-10 | Iniziato | Cowen | Outperform |
| 2020-08-10 | Iniziato | Goldman | Buy |
| 2020-08-10 | Iniziato | Guggenheim | Buy |
| 2020-08-10 | Iniziato | JP Morgan | Neutral |
Mostra tutto
Relay Therapeutics Inc Borsa (RLAY) Ultime notizie
Will earnings trigger a reversal in Relay Therapeutics Inc.July 2025 Chart Watch & Precise Entry and Exit Recommendations - Newser
Is Relay Therapeutics Inc. a cyclical or defensive stockJuly 2025 Breakouts & Low Drawdown Investment Strategies - خودرو بانک
Published on: 2025-09-01 11:06:23 - Newser
Momentum divergence signals in Relay Therapeutics Inc. chart2025 Market Sentiment & Risk Managed Trade Strategies - Newser
What’s the recovery path for long term holders of Relay Therapeutics Inc.July 2025 Review & Real-Time Chart Breakout Alerts - Newser
Why Relay Therapeutics Inc. is moving todayQuarterly Market Review & Daily Price Action Insights - Newser
How moving averages guide Relay Therapeutics Inc. tradingEntry Point & Long-Term Safe Investment Plans - Newser
What MACD signals say about Relay Therapeutics Inc.Weekly Profit Report & Free Real-Time Volume Trigger Notifications - Newser
News impact scoring models applied to Relay Therapeutics Inc.2025 Analyst Calls & Reliable Volume Spike Alerts - Newser
Advanced analytics toolkit walkthrough for Relay Therapeutics Inc.July 2025 Short Interest & Short-Term High Return Strategies - Newser
Relay Therapeutics Inc. stock daily chart insightsWeekly Stock Report & Fast Gaining Stock Reports - Newser
Traders Consider Averaging Down in Relay Therapeutics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
What technical models suggest about Relay Therapeutics Inc.’s comebackWeekly Stock Analysis & Short-Term High Return Ideas - Newser
Pattern recognition hints at Relay Therapeutics Inc. upsidePortfolio Performance Report & Consistent Return Investment Signals - Newser
Can Relay Therapeutics Inc. hit a new high this monthGap Down & AI Powered Trade Plan Recommendations - Newser
Using data tools to time your Relay Therapeutics Inc. exitJuly 2025 Patterns & Free Community Consensus Stock Picks - Newser
What makes Relay Therapeutics Inc. stock attractive todayJuly 2025 Retail & Low Drawdown Momentum Ideas - sundaytimes.kr
Will Relay Therapeutics (NASDAQ:RLAY) Spend Its Cash Wisely? - Yahoo Finance
How to read the order book for Relay Therapeutics Inc.Weekly Profit Analysis & Trade Opportunity Analysis Reports - Newser
Real time pattern detection on Relay Therapeutics Inc. stockEarnings Growth Report & Real-Time Volume Analysis - Newser
Ranking Relay Therapeutics Inc. among high performing stocks via toolsSwing Trade & Reliable Trade Execution Plans - Newser
Relay Therapeutics Inc. stock trend forecast2025 Top Decliners & Verified Stock Trade Ideas - Newser
Can Relay Therapeutics Inc. expand its profit marginsQuarterly Trade Summary & High Accuracy Investment Entry Signals - sundaytimes.kr
What does recent volatility data suggest for Relay Therapeutics Inc.Layoff News & Smart Swing Trading Techniques - Newser
Is Relay Therapeutics Inc. Forming a Consolidation BaseJuly 2025 Price Swings & Safe Investment Capital Preservation Plans - beatles.ru
Developing predictive dashboards with Relay Therapeutics Inc. data2025 Performance Recap & Reliable Intraday Trade Plans - Newser
Relay Therapeutics Inc Azioni (RLAY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Relay Therapeutics Inc Azioni (RLAY) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Rahmer Peter | See remarks |
Jul 28 '25 |
Sale |
3.74 |
1,359 |
5,083 |
393,722 |
| Catinazzo Thomas | Chief Financial Officer |
Jul 29 '25 |
Sale |
3.68 |
18,380 |
67,638 |
335,295 |
| Catinazzo Thomas | Chief Financial Officer |
Jul 28 '25 |
Sale |
3.74 |
1,701 |
6,362 |
353,675 |
| Bergstrom Donald A | President, R&D |
Jul 29 '25 |
Sale |
3.68 |
26,701 |
98,260 |
552,720 |
| Bergstrom Donald A | President, R&D |
Jul 28 '25 |
Sale |
3.74 |
4,069 |
15,218 |
579,421 |
| Adams Brian | Chief Legal Officer |
Jul 29 '25 |
Sale |
3.68 |
18,276 |
67,256 |
371,472 |
| Adams Brian | Chief Legal Officer |
Jul 28 '25 |
Sale |
3.74 |
1,637 |
6,122 |
389,748 |
| Patel Sanjiv | President and CEO |
Jul 09 '25 |
Sale |
3.57 |
61,379 |
219,123 |
765,288 |
| Rahmer Peter | See remarks |
Apr 30 '25 |
Sale |
3.00 |
10,739 |
32,217 |
390,081 |
| Rahmer Peter | See remarks |
Apr 28 '25 |
Sale |
3.17 |
1,364 |
4,324 |
400,820 |
0.96%
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):